Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Colorectal Neoplasms

Free Subscription 08.12.2025 1 Am J Surg 3 Ann Surg Oncol 4 Anticancer Res 1 BMC Cancer 1 Br J Surg 3 Cancer Res 1 Clin Cancer Res 7 Dis Colon Rectum 1 Eur J Cancer 3 Eur J Surg Oncol 2 Int J Cancer 5 Int J Colorectal Dis 1 J Natl Cancer Inst 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. CHANG ET, Jiang JK, Chang SC, Wang HS, et al
   The influence of neoadjuvant chemotherapy cycles on surgical complications in metastatic colon cancer.
   Am J Surg. 2025;252:116727.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. BOYER ME, Fleming FJ
   Rethinking Surgical Extent-Long-term Outcomes after Resection of T1 and T2 Colon Cancer.
   Ann Surg Oncol. 2025 Dec 3. doi: 10.1245/s10434-025-18831.
   PubMed        
   
   
3. ZHOU Y, Zuo Z, Zhao J, Tan Y, et al
   Development and Validation of Time-to-Event Machine Learning Models for Predicting Disease-Free Survival in Patients with Locally Advanced Colorectal Cancer: A Multicenter Cohort Study.
   Ann Surg Oncol. 2025 Dec 2. doi: 10.1245/s10434-025-18815.
   PubMed         Abstract available
   
   
4. RAQUEL SG, Cate DWGT, Lopez-Baamonde M, Bojesen RD, et al
   Adherence, Compliance Rates, and Response to Training Among Patients Awaiting Colorectal Cancer Surgery: A Secondary Analysis From the PREHAB Multicentre Trial.
   Ann Surg Oncol. 2025 Dec 1. doi: 10.1245/s10434-025-18668.
   PubMed         Abstract available
   
   

   
   Anticancer Res

5. MUECKE R, Fakhrian K, Gosenheimer R, Schmitz V, et al
   Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: A Single-institutional Real-world Study.
   Anticancer Res. 2025;45:5513-5521.
   PubMed         Abstract available
   
   
6. KIM J, Han Q, Li S, Kang BM, et al
   The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal Fibroblasts.
   Anticancer Res. 2025;45:5313-5320.
   PubMed         Abstract available
   
   
7. FURUKAWA K, Haruki K, Shirai Y, Onda S, et al
   Pulmonary Emphysema Assessed by the Goddard Score Predicts Outcomes After Hepatic Resection for Colorectal Liver Metastases.
   Anticancer Res. 2025;45:5765-5772.
   PubMed         Abstract available
   
   
8. YONEMITSU K, Kasashima H, Fukuoka T, Tanaka A, et al
   Successful Reconstruction of Recurrent Perineal Hernia After APR Using a Vertical Rectus Abdominis Myocutaneous Flap: A Salvage Option for a Refractory Case.
   Anticancer Res. 2025;45:5813-5817.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. PAN Y, Ying H, Luo M, Xuan Q, et al
   The co-location of MARCO + macrophages and SPOCK1 + fibroblasts contributes to the poor prognosis and undesirable immunotherapy response in colorectal cancer.
   BMC Cancer. 2025 Nov 28. doi: 10.1186/s12885-025-15397.
   PubMed        
   
   

   
   Br J Surg

10. 
    Multiple primary tumours in early-onset colorectal cancer: deciphering the risk.
    Br J Surg. 2025;112:znaf244.
    PubMed        
    
    

    
    Cancer Res

11. ZHAO J, Chen B, Deng Y, Fan L, et al
    ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion.
    Cancer Res. 2025;85:4701-4717.
    PubMed         Abstract available
    
    
12. DALAL PJ, Shah YM
    Gut Check: Lactobacillus johnsonii Harnesses Bile Acids and Reactive Oxygen Species to Suppress High-Fat Diet-Induced Colorectal Cancer.
    Cancer Res. 2025;85:4579-4581.
    PubMed         Abstract available
    
    
13. ARNOUK SM, Kancheva D, Van Damme H, Courtoy GE, et al
    Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
    Cancer Res. 2025;85:4681-4700.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

14. XIA F, Chen Y, Zhou D, Wan J, et al
    Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study.
    Clin Cancer Res. 2025;31:4976-4984.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

15. YEE JT, Eltahir AA, Oduyale OK, Dosch AR, et al
    Brave New World: Analysis of Early Clinical Experience With Molecular Sequencing in the Treatment of Rectal Cancer.
    Dis Colon Rectum. 2025;68:1414-1421.
    PubMed         Abstract available
    
    
16. KARAHAN SN, Oruc M, Erozkan K, Valente MA, et al
    Optimal Timing for Rectal Cancer Surgery After Total Neoadjuvant Therapy: When Does Surgery Get Really Challenging?
    Dis Colon Rectum. 2025;68:1403-1413.
    PubMed         Abstract available
    
    
17. GARFINKLE R, Balvardi S, Boutros M, Fergusson DA, et al
    Neoadjuvant Chemotherapy Without Radiation for Locally Advanced Rectal Cancer: A Meta-analysis of Surgical Outcomes After Total Mesorectal Excision.
    Dis Colon Rectum. 2025;68:1383-1391.
    PubMed         Abstract available
    
    
18. ZHOU J, Lv Q, Yang T, Li Y, et al
    Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Locally Advanced Rectal Cancer: A Multicenter Propensity Score-Matched Study.
    Dis Colon Rectum. 2025;68:1422-1432.
    PubMed         Abstract available
    
    
19. 
    Global Use and Outcomes of Endoscopic Stenting in Acute Malignant Left-Sided Colonic Obstruction: A Secondary Analysis of APOLLO, An International, Prospective Cohort Study.
    Dis Colon Rectum. 2025;68:1458-1467.
    PubMed         Abstract available
    
    
20. KARAHAN SN, Erkaya M, Oruc M, Steele SR, et al
    Risk of Distant Metastasis After Total Neoadjuvant Therapy: Local Regrowth Versus Surgery After Total Neoadjuvant Therapy With Pathologic Near-Complete Response in Rectal Cancer.
    Dis Colon Rectum. 2025;68:1433-1442.
    PubMed         Abstract available
    
    
21. ARARADIAN C, Erlick M, Goodyear S, Kardosh A, et al
    Pilot Study: Identification of the T-Cell Tumor Microenvironment of Premalignant and Malignant Anal Lesions.
    Dis Colon Rectum. 2025;68:1393-1402.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

22. HEINRICH K, Stintzing S, Weikersthal LFV, Decker T, et al
    Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
    Eur J Cancer. 2025;232:116133.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

23. YE Q, Liu M, Xu M, Cui M, et al
    Correlation of supportive proton pump inhibitor use during surgery with outcomes in patients with stage I-III colorectal cancer: A propensity score matching study.
    Eur J Surg Oncol. 2025;51:110543.
    PubMed         Abstract available
    
    
24. PAU S, Eglinton T, Wang A, Fischer J, et al
    Pre-operative predictors of completeness of cytoreduction for colorectal peritoneal metastases: a systematic review of radiological, clinicopathological and biomarker-based predictors.
    Eur J Surg Oncol. 2025;51:110537.
    PubMed         Abstract available
    
    
25. O'NEILL MA, Harrold EC, Gillham C, Ryan C, et al
    Immunotherapy for downstaging of locally advanced mismatch repair deficient colorectal cancer: A prospective institutional case series.
    Eur J Surg Oncol. 2025;52:111166.
    PubMed         Abstract available
    
    

    
    Int J Cancer

26. JAKOBSEN AV, Kronborg C, Ramlov A, Hvid CA, et al
    The prognostic value of cell-free DNA dynamics during chemoradiotherapy in squamous cell carcinomas of the anus.
    Int J Cancer. 2026;158:790-798.
    PubMed         Abstract available
    
    
27. GUADALAJARA H, Dominguez-Tristancho JL, Mateo RF, Leon-Arellano M, et al
    Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient-centered approach that clusters two cohorts with different outcomes.
    Int J Cancer. 2026;158:697-706.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

28. LEVENTI A, Sibbons P, Tsigka A, Korkolis D, et al
    Histological assessment of radiotherapy-induced injury in the anal canal: an exploratory study.
    Int J Colorectal Dis. 2025;40:246.
    PubMed         Abstract available
    
    
29. LI R, Zhao M, Ma Q, Zhang Z, et al
    MRI-defined high-risk rectal cancer patients: comparison of treatment response and survival outcomes between total neoadjuvant therapy and neoadjuvant chemoradiotherapy-a propensity score matched analysis.
    Int J Colorectal Dis. 2025;40:244.
    PubMed         Abstract available
    
    
30. TRUELSEN CG, Kronborg CS, Ramlov A, Hvid CA, et al
    Longitudinal assessment of quality of life and symptom burden in locally advanced rectal cancer patients receiving IMRT-based preoperative radiotherapy: A prospective cohort study.
    Int J Colorectal Dis. 2025;40:239.
    PubMed         Abstract available
    
    
31. SCHRAEPEN C, Bislenghi G, Vanhaecht K, Andre D'Hoore, et al
    Defining key interventions for rectal cancer surgery: a literature review and expert panel consensus.
    Int J Colorectal Dis. 2025;40:241.
    PubMed         Abstract available
    
    
32. LU Z, Yang W, Yang H, Sui X, et al
    Nomogram predicting short- and long-term outcomes in colon cancer based on CT body composition.
    Int J Colorectal Dis. 2025 Dec 2. doi: 10.1007/s00384-025-05016.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

33. CORONADO GD, Hoffman RM, Llavona-Ortiz J, Rutter CM, et al
    The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer.
    J Natl Cancer Inst. 2025 Dec 1:djaf341. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Oncogene

34. YANG LP, Huang JQ, Yeung CW, Zhang QH, et al
    Targeted methylation of cg24067911 suppresses colorectal cancer metastasis through BCL6-ATXN1-CDH1 axis.
    Oncogene. 2025 Dec 2. doi: 10.1038/s41388-025-03638.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.